March 29, 2024

DUBLIN, April 7, 2022 /PRNewswire/ — The “Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026” report has been added to ResearchAndMarkets.com’s offering.

Research_and_Markets_Logo

The report provides an in-depth analysis of the Global RNAi therapeutics market by value, by molecule type, by application, by region, etc. The report provides a regional analysis of the RNAi therapeutics market, including North America (The US, Canada, and Mexico), Europe, Asia Pacific, Middle East & Africa, and Latin America. The report further provides a detailed analysis of the US market on the basis of molecule type, and application. The report also provides an analysis of the COVID-19 impact on the RNAi therapeutics market.

The RNAi therapeutics market can be segmented on the basis of molecule type (small interference RNA (siRNA), and micro RNA (miRNA)), and application (oncology, cardiovascular disorders, respiratory disorders, renal diseases, genetic disorders, neurodegenerative disorders, infectious diseases, and others).

While most of the industries worldwide suffered a negative impact of COVID-19, the RNAi therapeutics market witnessed a positive impact on it. Initially, the market witnessed a sudden spike in the demand, since the relevance of RNAi research in understanding the COVID-19 virus started growing mainly during the initial worldwide outbreak of COVID-19, in 2020.

Later in the year…

Read more…

Leave a Reply

Your email address will not be published. Required fields are marked *